ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,324.925
-0.12%
Brent Oil
84.865
-0.64%
Bitcoin
60,097.91
-2.46%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ALX Oncology Holdings Inc (ALXO) Share Price

ALXO ALX Oncology Holdings Inc

5.81
-0.025 (-0.43%)
After Hours
Last Updated: 20:49:29
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 ALX Oncology Holdings Inc NASDAQ:ALXO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.025 -0.43 5.81 5.79 5.82 6.03 5.55 5.68 938,118 19:49:29   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -160.81M -3.0865 -1.87 300.62M
 Type  Size  Price  Time  Units 
 9 1 5.805 19:49:38 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ALXO News
17/06/202421:21EDGAR2Form 8-K - Current report
06/06/202421:06EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
04/06/202421:14EDGAR2Form 144 - Report of proposed sale of securities
02/06/202415:00GLOBEALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
29/05/202414:00GLOBEALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
15/05/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
13/05/202421:06EDGAR2Form 144 - Report of proposed sale of securities
Period
Draw mode
Data Downloads for ALXO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest ALX Oncology Holdings Inc Articles